SHERYL GYR: Open Payments
NPI 1578765970 · MURPHY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$510 in 24 payments from 8 companies in 2025. Trend: 2023 $981 · 2024 $2,428 · 2025 $510
Food & beverage: $510
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $151 |
| Amgen Inc. | 3 | $86 |
| GENZYME CORPORATION | 3 | $69 |
| Novartis Pharmaceuticals Corporation | 2 | $66 |
| UCB, Inc. | 2 | $46 |
| Arcutis Biotherapeutics, Inc. | 2 | $37 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $37 |
| Lilly USA, LLC | 1 | $19 |
Products named: SKYRIZI, DUPIXENT, OTEZLA, Bimzelx, RINVOQ, Zoryve, Winlevi, COSENTYX.
Industry payments across TX — which companies pay providers there.
